Profile
Xu Zhu is currently the Director at EverID Medicines Ltd. Previously, she held executive director positions at AstraZeneca UK Ltd. and Astrazeneca Pharmaceutical Technology Beijing Co. Ltd. from 2003 to 2013.
Prior to that, she worked as the Manager-Clinical Research at MSD China Holding Co. Ltd. from 1995 to 2003.
Ms. Zhu also serves as the Chief Medical Officer-Infectious Disease at Everest Medicines Ltd. In terms of education, she graduated from Peking University Health Science Center in 2009 and completed her undergraduate degree at Beijing Medical University in 1994.
Xu Zhu active positions
| Companies | Position | Start |
|---|---|---|
EverID Medicines Ltd. | Director/Board Member | - |
Former positions of Xu Zhu
| Companies | Position | End |
|---|---|---|
AstraZeneca UK Ltd.
AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services Manufactures pharmaceutical products | Corporate Officer/Principal | 01/04/2013 |
Astrazeneca Pharmaceutical Technology Beijing Co. Ltd. | Corporate Officer/Principal | 01/04/2013 |
MSD China Holding Co. Ltd. | Corporate Officer/Principal | 01/01/2003 |
| EVEREST MEDICINES LIMITED | Corporate Officer/Principal | - |
Training of Xu Zhu
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
AstraZeneca UK Ltd.
AstraZeneca UK Ltd. Miscellaneous Commercial ServicesCommercial Services Manufactures pharmaceutical products | Commercial Services |
Peking University Health Science Center
Peking University Health Science Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Beijing Medical University
Beijing Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MSD China Holding Co. Ltd. | |
Everest Medicines Ltd.
Everest Medicines Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes therapies to address critical unmet medical needs | Health Technology |
EverID Medicines Ltd. | |
Astrazeneca Pharmaceutical Technology Beijing Co. Ltd. |
- Stock Market
- Insiders
- Xu Zhu
















